By Ian DeMeritt, PhD (@idemeritt)
As printed promotional materials are continually being replaced by flashier electronic detail aids and on-line content, it is not surprising that DDMAC continues to cast a regulatory eye on digital presentations of pharmaceutical advertisements. Last April, they fired a resounding shot across the bow of the pharma world that sent a [...]
Tags:advertising·Compliance·DDMAC·digital media·digital strategy·drug safety·Education·FDA·Pharma·technology·Web Design·World Wide Web
By Guy Mastrion (@gmastrion)
Socialized Compliance with Social Media.
I’m thinking a lot lately about the potential for the positive impact social media will have on compliance efforts, the high, Holy Grail of healthcare.
Will social media get compliance issues unstuck? Will it be any one form or will it entail many forms? Will only certain patient types [...]
Tags:communication·Communities·Compliance·drug safety·Education·listening posts·Patients·Pharma·social media·Social network·Trends·User Experience·user needs
By Sven Larsen (@zemoga)
What will the Pharma industry be like in 2010?
Even though there are only 10 days left in 2009 I don’t think that’s a question anyone can accurately answer. Not because there’s a lack of experts who could make educated guesses. But because events continue to transpire that cloud the crystal ball for [...]
Tags:drug safety·Health Care Reform·Pharma·Pharmaceutical industry·prescription drug costs·Thought Leaders·Trends
By Sven Larsen (@zemoga)
Do you have all your holiday shopping done yet? if you’re like most of us you’ve probably received wish lists from your friends and family, so you know what kind of gifts they would like this holiday season.
Well in the interest of public service I thought I would do the same for [...]
Tags:communication·Communities·Digital Tools·drug safety·Education·FDA·Health care·marketing·media·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
By Guy Mastrion (@gmastrion)
We’ve been grousing about how pharma doesn’t take its own reputation seriously enough. So we decided, okay, let’s be productive and think of ways to better that. First question. Are there better venues to educate the public about drug performance and the issues facing the industry?
Put another way? There’s got to be new [...]
Tags:advertising·communication·Communities·drug safety·Education·media·Patients·Pharma·Pharmaceutical industry·Thought Leaders·User Experience
By Steve Dubansky, MD
Are you ready for 10 minute long DTC commercials?
The seemingly never-ending debate about the risks and benefits of DTC drug advertising continues to rage between Pharma and the concerned, self-designated protectors of the public health. Do prescription drug ads educate consumers, improve the quality of care, and contribute to better patient adherence, [...]
Tags:advertising·branding·Compliance·drug safety·DTC·Education·FDA·Legal Issues·marketing·media·Pharma·Pharmaceutical industry·Risk mitigation·Trends·user needs
Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for healthcare professionals.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Robert Winder, CEO of VuMedi talks about educating Health Care Professionals and how company concerns about FDA Regulations can actually impede information distribution.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Mark Senak, SVP of Fleishman-Hillard and author of the EYE ON FDA blog declares “the system is broken” and offers the FDA some advice on how to deal with the media.
Tags:#fdasm·advertising·Blogs·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·media·Pharma·social media·Thought Leaders·Trends
Live (almost) from the FDA hearings in Washington, Fard Johnmar founder of Envision Solutions explains how research can give us greater insight in to consumer use of social media (and how the FDA can utilize this information).
Tags:advertising·communication·Communities·Compliance·Conferences·data·digital strategy·Digital Tools·drug safety·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
